ArticleInternational journal of clinical oncology2019

Body composition as a predictor of toxicity after treatment with eribulin for advanced soft tissue sarcoma.

Hiroshi Kobayashi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.